ALNY
Price
$320.52
Change
-$0.01 (-0.00%)
Updated
Jul 21 closing price
Capitalization
41.79B
9 days until earnings call
UTHR
Price
$293.12
Change
+$1.11 (+0.38%)
Updated
Jul 21 closing price
Capitalization
13.22B
8 days until earnings call
Interact to see
Advertisement

ALNY vs UTHR

Header iconALNY vs UTHR Comparison
Open Charts ALNY vs UTHRBanner chart's image
Alnylam Pharmaceuticals
Price$320.52
Change-$0.01 (-0.00%)
Volume$744.53K
Capitalization41.79B
United Therapeutics
Price$293.12
Change+$1.11 (+0.38%)
Volume$279.83K
Capitalization13.22B
ALNY vs UTHR Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. UTHR commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and UTHR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ALNY: $320.52 vs. UTHR: $293.12)
Brand notoriety: ALNY and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 85% vs. UTHR: 51%
Market capitalization -- ALNY: $41.79B vs. UTHR: $13.22B
ALNY [@Biotechnology] is valued at $41.79B. UTHR’s [@Biotechnology] market capitalization is $13.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 3 TA indicator(s) are bullish while UTHR’s TA Score has 3 bullish TA indicator(s).

  • ALNY’s TA Score: 3 bullish, 5 bearish.
  • UTHR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ALNY and UTHR are a bad buy in the short-term.

Price Growth

ALNY (@Biotechnology) experienced а +1.51% price change this week, while UTHR (@Biotechnology) price change was -1.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($41.8B) has a higher market cap than UTHR($13.2B). ALNY YTD gains are higher at: 36.212 vs. UTHR (-16.926). UTHR has higher annual earnings (EBITDA): 1.68B vs. ALNY (-152.58M). UTHR has more cash in the bank: 3.32B vs. ALNY (2.63B). UTHR has less debt than ALNY: UTHR (200M) vs ALNY (1.3B). UTHR has higher revenues than ALNY: UTHR (2.99B) vs ALNY (2.35B).
ALNYUTHRALNY / UTHR
Capitalization41.8B13.2B317%
EBITDA-152.58M1.68B-9%
Gain YTD36.212-16.926-214%
P/E RatioN/A11.68-
Revenue2.35B2.99B78%
Total Cash2.63B3.32B79%
Total Debt1.3B200M651%
FUNDAMENTALS RATINGS
ALNY vs UTHR: Fundamental Ratings
ALNY
UTHR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
2333
SMR RATING
1..100
10045
PRICE GROWTH RATING
1..100
4261
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (66) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALNY (99) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (23) in the Biotechnology industry is in the same range as UTHR (33) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALNY (100) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Price Growth Rating (42) in the Biotechnology industry is in the same range as UTHR (61) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's P/E Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as ALNY (100) in the Biotechnology industry. This means that UTHR’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYUTHR
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
55%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
60%
MACD
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 14 days ago
66%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
67%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TAN38.360.37
+0.97%
Invesco Solar ETF
ASIA30.090.19
+0.63%
Matthews Pacific Tiger Active ETF
XTRE49.550.05
+0.10%
BondBloxx Bloomberg ThreeYrTrgDurUSTrETF
XMAG21.27-0.01
-0.05%
Defiance Large Cap ex-Mag 7 ETF
DFAT55.27-0.08
-0.14%
Dimensional US Targeted Value ETF

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.00%
IONS - ALNY
59%
Loosely correlated
-0.50%
ARGX - ALNY
42%
Loosely correlated
+0.27%
INSM - ALNY
40%
Loosely correlated
-1.33%
TECH - ALNY
40%
Loosely correlated
-3.36%
CRNX - ALNY
38%
Loosely correlated
-0.51%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+0.38%
DAWN - UTHR
39%
Loosely correlated
N/A
MNKD - UTHR
38%
Loosely correlated
+1.60%
GERN - UTHR
37%
Loosely correlated
-0.81%
CERO - UTHR
33%
Poorly correlated
-4.24%
ALNY - UTHR
32%
Poorly correlated
-0.00%
More